Sign inJoin waitlistJoin the waitlist

Robert Schooley

Co-Director, The Center for Innovative Phage Applications and Therapeutics · University of California (San Diego) Medical Center

Credentials: · ·

History

The Center for Innovative Phage Applications and Therapeutics · University of California (San Diego) Medical Center
Present
Department of Medicine · University of California (San Diego) Medical Center
Present
Medicine · University of California (San Diego) Medical Center
Present

Infectious Disease
1977–1979
Internal Medicine
1974–1977
Johns Hopkins Univ Sch of Med
1970–1974

Research

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
New England Journal of Medicine · 1987 · 2,322 citations
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Case report · Nature Medicine · 2019 · 1,075 citations
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome
Case report · New England Journal of Medicine · 1985 · 1,026 citations

MH
Martin Hirsch
66 papers
Constance Benson
31 papers
DR
Douglas Richman
19 papers
Paul Volberding
17 papers
Daniel Kuritzkes
16 papers · 1 as a fellow
MT
Melanie Thompson
15 papers
Saima Aslam
15 papers
Michael Saag
14 papers
Thomas Campbell
14 papers
DP
David Pride
13 papers
Margaret Fischl
13 papers
SH
Scott Hammer
12 papers

Grants

Orally Bioavailable Antiviral Drugs with Broad Pandemic Virus Activity
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.1M · University of California, San Diego
2021–2031
San Diego Center for AIDS Research (SD CFAR)
National Institute of Allergy and Infectious Diseases · P30
Project lead · $3.5M · University of California, San Diego
1997–2028
Enhancing Advanced Biomedical Training in Mozambique
Fogarty International Center · D43
Contact PI · $1.5M · University of California, San Diego
2017–2023
Development of Sustained-Release Anti-Coronavirus Nucleoside Phosphonate Compounds
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.8M · University of California, San Diego
2017–2022

Clinical trials

Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2004–2011